HLS Therapeutics
About:
HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity.
Website: http://www.hlstherapeutics.com/
Top Investors: Silicon Valley Bank, JP Morgan Chase, HealthCor Partners
Description:
HLS is dedicated to the stewardship of branded pharmaceuticals through their life cycles post - exclusivity. HLS ensures the availability of treatments critical to patients and their caregivers with the brand names they trust.
Total Funding Amount:
$283M
Estimated Revenue Range:
$50M to $100M
Headquarters Location:
Caledon, Ontario, Canada
Founded Date:
2014-01-01
Contact Email:
g.godin(AT)hlstherapeutics.com
Founders:
Gilbert Godin, Gregory D. Gubitz
Number of Employees:
51-100
Last Funding Date:
2022-10-03
IPO Status:
Public
Industries:
© 2025 bioDAO.ai